載入...
Immunosuppression in chronic autoimmune neurological disorders during the COVID-19 pandemic
OBJECTIVE: To study the risk of acquiring Corona Virus Disease 2019 (COVID-19) and its outcomes in patients on immunosuppressive therapy (IST) for chronic autoimmune neuromuscular disorders (aNMD) and multiple sclerosis (MS). METHODS: We used TriNetX, a global health collaborative clinical research...
Na minha lista:
| 發表在: | J Neurol Sci |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Elsevier B.V.
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7837234/ https://ncbi.nlm.nih.gov/pubmed/33256952 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jns.2020.117230 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|